(firstQuint)A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs.

 All enrolled patients will receive the following 3 drug combination: Saquinavir, Zidovudine and Lamivudine.

 Efficacy and duration of anti-viral response will be evaluated by monitoring of HIV-1 RNA levels.

 Patients below the detectable limit of 200 copies/ml will be analyzed using the Ultra-direct method with a detection limit of 20 copies/ml.

 CD4 and CD8 cell counts will also be analyzed.

.

 A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs@highlight

To evaluate the efficacy of Saquinavir-SGC combination with Zidovudine and Lamivudine in the treatment of HIV-1 infected patients with no previous anti-retroviral drug therapy.

